Akston Health
Akston Health
As a leader in global nutraceutical sourcing, Qingdao Akston Health recognizes that Bitter Orange Extract (Citrus aurantium) is more than a commodity—it is a sophisticated bio-active ingredient. Leveraging p-synephrine standardization, we bridge the gap between Chinese botanical innovation and global pharmaceutical rigor.
The future of Bitter Orange Extract lies in Green Extraction Technology. Our roadmap focuses on subcritical fluid extraction to preserve volatile compounds while maximizing alkaloids. By 2026, we aim for zero-solvent residue benchmarks, positioning our manufacturing as the gold standard for global supplement brands.
Our vertical integration ensures that from the citrus orchards of Sichuan and Hunan to the finished GMP-certified facility, every batch is traceable. This transparency provides our partners with a competitive edge, mitigating geopolitical and supply risks through proactive raw material hedging and digital inventory management.
A: We utilize HPLC/LC-MS testing validated by independent third-party labs to ensure exact standardization and absence of heavy metals.
A: We offer 24/7 technical documentation, REACH/FDA compliance dossiers, and localized logistics support for seamless entry into EU and US markets.
Qingdao Akston Health operates under the strict Search Quality Rater Guidelines mindset. We don't just sell ingredients; we provide "Information Gain"—the technical data, clinical summaries, and manufacturing insights that empower your R&D teams to create superior market-ready products.